<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101264945</journal-id>
<journal-id journal-id-type="pubmed-jr-id">34537</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Opin HIV AIDS</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Opin HIV AIDS</journal-id>
<journal-title-group>
<journal-title>Current opinion in HIV and AIDS</journal-title>
</journal-title-group>
<issn pub-type="ppub">1746-630X</issn>
<issn pub-type="epub">1746-6318</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26371462</article-id>
<article-id pub-id-type="pmc">4982533</article-id>
<article-id pub-id-type="doi">10.1097/COH.0000000000000203</article-id>
<article-id pub-id-type="manuscript">EMS66575</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Herbst</surname>
<given-names>Kobus</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Law</surname>
<given-names>Matthew</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geldsetzer</surname>
<given-names>Pascal</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tanser</surname>
<given-names>Frank</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Harling</surname>
<given-names>Guy</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bärnighausen</surname>
<given-names>Till</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Wellcome Trust Africa Centre for Health and Population Studies, UKZN, Somkhele, South Africa</aff>
<aff id="A2"><label>2</label>The Kirby Institute, UNSW Australia, Sydney, NSW 2052, Australia</aff>
<aff id="A3"><label>3</label>Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02138, USA</aff>
<aff id="A4"><label>4</label>School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa</aff>
<aff id="A5"><label>5</label>INDEPTH Network, Accra, Ghana</aff>
<author-notes>
<corresp id="CR1">Corresponding author: Kobus Herbst. Address: PO Box 198, Mtubatuba, 3935, South Africa, Telephone: +27355507503 (W) +27355507565 (Fax), <email>kherbst@africacentre.ac.za</email></corresp>
<fn fn-type="conflict" id="FN1">
<p id="P24">Conflicts of interest</p>
<p id="P25">The authors did not declare any conflict of interest. ML’s institution received funding from Boehringer Ingelheim, Gilead Sciences, Merck Sharp &amp; Dohme, Bristol-Myers Squibb, Janssen-Cilag, ViiV HealthCare. ML received DSMB sitting fees from Sirtes Pty Ltd.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>11</month>
<year>2015</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>12</day>
<month>8</month>
<year>2016</year>
</pub-date>
<volume>10</volume>
<issue>6</issue>
<fpage>483</fpage>
<lpage>494</lpage>
<!--elocation-id from pubmed: 10.1097/COH.0000000000000203-->
<abstract>
<sec id="S1">
<title>Purpose of Review</title>
<p id="P1">Health and Demographic Surveillance Systems (HDSS), in conjunction with HIV treatment cohorts, have made important contributions to our understanding of the impact of HIV treatment and treatment-related interventions in sub-Saharan Africa. The purpose of this review is to describe and discuss innovations in data collection and data linkage that will create new opportunities to establish the impacts of HIV treatment, as well as policies affecting the treatment cascade, on population health, economic and social outcomes.</p>
</sec>
<sec id="S2">
<title>Recent Findings</title>
<p id="P2">Novel approaches to routine collection of (i) biomarkers, (ii) behavioural data, (iii) spatial data, (iv) social network information, (v) migration events and (vi) mobile phone records can significantly strengthen the potential of HDSS to generate exposure and outcome data for causal analysis of HIV treatment impact and policies affecting the HIV treatment cascade. Additionally, by linking HDSS data to health service administration, education, and welfare service records, researchers can substantial broaden opportunities to establish how HIV treatment affects health and economic outcomes, when delivered through public-sector health systems and at scale.</p>
</sec>
<sec id="S3">
<title>Summary</title>
<p id="P3">As the HIV treatment scale-up in sub-Saharan Africa enters its second decade, it is becoming increasingly important to understand the long-term causal impacts of large-scale HIV treatment and related policies on broader population health outcomes, such as non-communicable diseases, as well as on economic and social outcomes, such as family welfare and children’s educational attainment. By collecting novel data and linking existing data to public-sector records, HDSS can create near-unique opportunities to contribute to this research agenda.</p>
</sec>
</abstract>
<kwd-group>
<kwd>Health and Demographic Surveillance</kwd>
<kwd>treatment Cohorts</kwd>
<kwd>data collection</kwd>
<kwd>data linkage</kwd>
<kwd>biomeasures</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>